5:01 PM
 | 
Apr 24, 2013
 |  BC Extra  |  Company News

Janssen submits simeprevir MAA

The Janssen-Cilag International N.V. unit of Johnson & Johnson (NYSE:JNJ) submitted an MAA to EMA for simeprevir ( TMC435) to...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >